Why the handoff point decides how much rework you carry
A compounded prescription must satisfy the 503A supplier on three fronts: a complete and fillable SIG, a prescriber licensed in the patient's state, and available stock. When those checks live only at the supplier — after the order is submitted — any failure becomes a rejection that bounces back to the clinic, and the prescriber has to re-authorize or correct before the order can move again. VSDH public materials do not foreground a pre-submit validation step, so this is the typical friction point in ConnectRxCare and API flows.
Fizy Health validates the prescription details before they reach the supplier. Cart validation checks the SIG, prescriber state licensure, and stock before checkout, so the prescription that hands off to the 503A partner is one it can actually fill. That moves rework out of the prescriber's day and reduces the rejected-prescription loop — especially on high-volume GLP-1 refill days when one wave of rejections can consume an afternoon.